Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

Vaccine

Volumn 27, Issue 38, 2009, Pages 5184-5186

  Collin, Nicolas ^a   de Radiguès, Xavier ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

A(H1N1) influenza; Capacity; Influenza; Pandemic; Production; Seasonal; Vaccine

Indexed keywords

INFLUENZA VACCINE; TRIPLE VACCINE;

ARTICLE; DRUG MANUFACTURE; HIGH RISK POPULATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEASONAL VARIATION; VACCINE PRODUCTION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; WORLD HEALTH ORGANIZATION;

EID: 67651083650     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.034     Document Type: Article

References (5)

1. Ferguson N.M., Cummings D.A., Fraser C., Cajka J.C., Cooley P.C., and Burke D.S. Strategies for mitigating an influenza pandemic. Nature 442 7101 (2006) 448-452
2. Kieny M.P., and Fukuda K. The pandemic influenza challenge. Vaccine 26 Suppl. 4 (2008) D3-4
3. http://www.ifpma.org/pdf/2009_04_21_Release_IVS_Wyman_Capacity_24Feb09.pdf, consulted 4 June 2009.
4. Kieny M.P., Costa A., Hombach J., Carrasco P., Pervikov Y., Salisbury D., et al. A global pandemic influenza vaccine action plan. Vaccine 24 40-41 (2006) 6367-6370
5. Palache B., and Krause R. Progress with human H5N1 vaccines: a perspective from industry. Expert Rev Vaccines 8 4 (2009) 391-400